| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $35.2M | +12.4% |
| Cost of Revenue | $7.3M | +4.1% |
| Gross Profit | $27.9M | +14.8% |
| R&D Expense | $5.1M | -27.4% |
| SG&A Expense | $13.6M | +17.8% |
| Operating Income | -$3.4M | +43.2% |
| Net Income | -$4.3M | +27.6% |
| EPS (Basic) | -$0.36 | +28.0% |
| EPS (Diluted) | -$0.36 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.7M | -38.8% |
| Accounts Receivable | $5.9M | +22.9% |
| Current Assets | $12.1M | -18.0% |
| Total Assets | $29.8M | +16.8% |
| Current Liabilities | $11.6M | +0.4% |
| Long-term Debt | $6.8M | +1.4% |
| Total Liabilities | $20.3M | +8.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.7M | +758.8% |
| Capital Expenditures | $128K | -25.1% |
| Investing Cash Flow | -$7.2M | -234.6% |
| Financing Cash Flow | $898K | -78.5% |
| Free Cash Flow | $2.6M | +1670.7% |
| +28.0% |
| Stockholders' Equity |
| $9.4M |
| +40.7% |